These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25545882)

  • 1. Safety, sterility and stability of direct-from-vial multiple dosing intravitreal injection of bevacizumab.
    Das T; Volety S; Ahsan SM; Thakur AK; Sharma S; Padhi TR; Basu S; Rao ChM
    Clin Exp Ophthalmol; 2015 Jul; 43(5):466-73. PubMed ID: 25545882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the sterility, stability, and efficacy of bevacizumab stored in multiple-dose vials for 6 months.
    Chen YH; Wu PC; Shiea J; Lo LH; Wu YC; Kuo HK
    J Ocul Pharmacol Ther; 2009 Feb; 25(1):65-9. PubMed ID: 19232008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bevacizumab sterility in multiple doses from a single-use vial.
    Ornek K; Karahan ZC; Ergin A; Tekeli A; Tekeli O
    Ann Pharmacother; 2008 Oct; 42(10):1425-8. PubMed ID: 18765834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study on the contamination of injection bevacizumab on storage of multidose vials.
    Saoji K; Trehan H; Narayanan R; Verma L
    Indian J Ophthalmol; 2018 Feb; 66(2):252-255. PubMed ID: 29380769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of Cell-Penetrating Peptide anti-VEGF Formulations for the Treatment of Age-Related Macular Degeneration.
    Nikoi ND; Berwick M; Bryant JA; Riordan L; Slope L; Peacock AFA; de Cogan F
    Curr Eye Res; 2021 May; 46(5):751-757. PubMed ID: 33896277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevacizumab for Intravitreal Injection: Impact of Sub-Visible Particles on the Shelf-Life of Repackaged Bevacizumab.
    Crul M; Zandvliet A; Moes JR; Veenbaas T; Smeets O
    J Ocul Pharmacol Ther; 2019; 35(6):372-375. PubMed ID: 31259653
    [No Abstract]   [Full Text] [Related]  

  • 7. Stability of Bevacizumab Divided in Multiple Doses for Intravitreal Injection.
    Phasukkijwatana N; Tanterdtham J; Lertpongparkpoom D
    J Med Assoc Thai; 2015 Aug; 98(8):798-803. PubMed ID: 26437538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INCIDENCE OF SUSTAINED OCULAR HYPERTENSION USING PREPACKAGED VERSUS FRESHLY PREPARED INTRAVITREAL BEVACIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Storey PP; Ho V; Yeh S; Reddy S; Fang-Yen NH; Pequignot E; Leiby BE; Fineman M; Garg S; Hubbard GB; Hsu J
    Retina; 2015 Oct; 35(10):1992-2000. PubMed ID: 26035396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Storage stability of bevacizumab in polycarbonate and polypropylene syringes.
    Khalili H; Sharma G; Froome A; Khaw PT; Brocchini S
    Eye (Lond); 2015 Jun; 29(6):820-7. PubMed ID: 25853399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing.
    Bakri SJ; Snyder MR; Pulido JS; McCannel CA; Weiss WT; Singh RJ
    Retina; 2006; 26(5):519-22. PubMed ID: 16770257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LONG-TERM PHYSICAL STABILITY, STERILITY, AND ANTI-VEGF BIOACTIVITY OF REPACKAGED BEVACIZUMAB IN 2-ML GLASS VIALS.
    Peterson JS; Rockwell K; Scott IU; Ip MS; VanVeldhuisen PC; Blodi BA;
    Retina; 2019 Sep; 39(9):1802-1809. PubMed ID: 29746405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of compounded bevacizumab prepared for intravitreal injection.
    Yannuzzi NA; Klufas MA; Quach L; Beatty LM; Kaminsky SM; Crystal RG; D'Amico DJ; Kiss S
    JAMA Ophthalmol; 2015 Jan; 133(1):32-9. PubMed ID: 25233052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of bevacizumab (Avastin®) repacked in single-use glass vials for intravitreal administration.
    Sugimoto MAA; Toledo VPCP; Cunha MRR; Carregal VM; Jorge R; Leão P; Fialho SL; Silva-Cunha A
    Arq Bras Oftalmol; 2017; 80(2):108-113. PubMed ID: 28591284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term stability of bevacizumab repackaged in 1mL polypropylene syringes for intravitreal administration.
    Paul M; Vieillard V; Roumi E; Cauvin A; Despiau MC; Laurent M; Astier A
    Ann Pharm Fr; 2012 May; 70(3):139-54. PubMed ID: 22655582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification, microbial contamination, physico-chemical stability of repackaged bevacizumab stored under different conditions.
    Signorello L; Pucciarelli S; Bonacucina G; Polzonetti V; Cespi M; Perinelli DR; Palmieri GF; Pettinari R; Pettinari C; Fiorentini G; Vincenzetti S
    Curr Pharm Biotechnol; 2014; 15(2):113-9. PubMed ID: 24953231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avastin doesn't blind people, people blind people.
    Gonzalez S; Rosenfeld PJ; Stewart MW; Brown J; Murphy SP
    Am J Ophthalmol; 2012 Feb; 153(2):196-203.e1. PubMed ID: 22264942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreomacular Interface after Anti-Vascular Endothelial Growth Factor Injections in Neovascular Age-Related Macular Degeneration.
    Veloso CE; Kanadani TM; Pereira FB; Nehemy MB
    Ophthalmology; 2015 Aug; 122(8):1569-72. PubMed ID: 26038338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.
    Yamashiro K; Tsujikawa A; Miyamoto K; Oh H; Otani A; Tamuara H; Ooto S; Sasahara M; Iwama D; Yoshimura N
    Retina; 2010 Mar; 30(3):485-90. PubMed ID: 19952993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.